Eiko Lifesciences Closes Trading Window for Insider Trading

Eiko Lifesciences Ltd has announced the closure of its trading window for designated persons and their immediate relatives. The closure will be effective from Wednesday, July 1, 2026, and will remain in effect for 48 hours after the upcoming Board Meeting. This meeting is scheduled to consider, among other items, the Un-Audited Standalone and Consolidated Financial Results for the quarter ended June 30, 2026. The exact date of the Board Meeting will be communicated separately. This measure is in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015, and the company's internal code of conduct, to prevent potential insider trading.